2,4-thiazolidinedione

2,4-thiazolidinedione is a small molecule compound and the parent structure of the thiazolidinedione class (also known as glitazones), which are heterocyclic compounds with a five-membered C3NS ring. It acts as an insulin sensitizer by serving as an agonist of peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear receptor that regulates gene expression involved in glucose and lipid metabolism. This mechanism enhances insulin sensitivity and improves glucose uptake in peripheral tissues. While 2,4-thiazolidinedione itself is primarily used in research settings rather than directly as a pharmaceutical agent, it serves as the core scaffold for clinically approved drugs such as pioglitazone and rosiglitazone for type 2 diabetes mellitus. The compound has also been investigated for its anti-inflammatory, antioxidant properties, and potential applications in cancer therapy[1][5][7][8].

Other names

thiazolidine-2,4-dione